As of 2024-12-11, the Intrinsic Value of HAVN Life Sciences Inc (HAVN.CN) is
-2.74 CAD. This HAVN.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.03 CAD, the upside of HAVN Life Sciences Inc is
-9,239.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.74 CAD
Intrinsic Value
HAVN.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.74 - -2.74 |
-2.74 |
-9,239.57% |
| P/E |
(1.25) - (1.32) |
(1.33) |
-4532.7% |
| DDM - Stable |
(7.55) - (52.93) |
(30.24) |
-100890.5% |
| DDM - Multi |
0.00 - 0.00 |
0.00 |
-100.0% |
HAVN.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.86 |
| Beta |
5.07 |
| Outstanding shares (mil) |
28.65 |
| Enterprise Value (mil) |
0.87 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.01% |
| Cost of Debt |
5.00% |
| WACC |
5.35% |